Helicobacter pylori Infection: Current Status and Future Prospects on Diagnostic, Therapeutic and Control Challenges
Antibiotics · 17.01.2023 · 12 (2) · 191
DOI: 10.3390/antibiotics12020191 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antibiotics, online erschienen am 17.01.2023. Verfasst von Ayman Elbehiry und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health, College of Public Health and Health Informatics, Qassim University, Al Bukayriyah 52741, Saudi Arabia. Die Arbeit wurde bisher 189-mal zitiert (Crossref) und nennt 218 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deputyship for Research & Innovation, Ministry of Education, Saudi Arabia.
Abstract (Originalsprache)
Helicobacter pylori (H. pylori) infection, which affects approximately half of the world’s population, remains a serious public health problem. As H. pylori infection leads to a number of gastric pathologies, including inflammation, gastroduodenal ulcers, and malignancies, early detection and treatment are crucial to preventing the spread of the infection. Multiple extragastric complications, such as iron deficiency anaemia, immune thrombocytopenic purpura, vitamin B12 deficiency, diabetes mellitus, cardiovascular diseases, and certain neurological disorders, have also been linked to H. pylori infection. An awareness of H. pylori and associated health hazards is necessary to minimize or even eradicate the infection. Therefore, there is an urgent need to raise the standards for the currently employed diagnostic, eradication, alternative treatment strategies. In addition, a brief overview of traditional and cutting-edge approaches that have proven effective in identifying and managing H. pylori is needed. Based on the test and laboratory equipment available and patient clinical characteristics, the optimal diagnostic approach requires weighing several factors. The pathophysiology and pathogenic mechanisms of H. pylori should also be studied, focusing more on the infection-causing virulence factors of this bacterium. Accordingly, this review aims to demonstrate the various diagnostic, pathophysiological, therapeutic, and eradication tactics available for H. pylori, emphasizing both their advantages and disadvantages. Invasive methods (such as quick urease testing, biopsy, or culture) or noninvasive methods (such as breath tests, stool investigations, or serological tests) can be used. We also present the most recent worldwide recommendations along with scientific evidence for treating H. pylori. In addition to the current antibiotic regimens, alternative therapies may also be considered. It is imperative to eradicate the infections caused by H. pylori as soon as possible to prevent problems and the development of stomach cancer. In conclusion, significant advances have been made in identifying and treating H. pylori. To improve eradication rates, peptide mass fingerprinting can be used as a diagnostic tool, and vaccines can also eliminate the infection.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Public Health, College of Public Health and Health Informatics, Qassim University, Al Bukayriyah 52741, Saudi Arabia.
- Department of Bacteriology, Mycology and Immunology, Faculty of Veterinary Medicine, University of Sadat City, Sadat City 32511, Egypt.
- Department of Veterinary Medicine, College of Agriculture and Veterinary Medicine, Qassim University, Buraydah 52571, Saudi Arabia.
- Department of Preventive Medicine, King Fahad Armed Hospital, Jeddah 23311, Saudi Arabia.
- Medical Emergency Services Department, Faculty of Health Sciences, Umm Al-Qura University, Al-Qunfudah P.O. Box 1109, Saudi Arabia.
- Biology Department, College of Science, Jouf University, Sakaka 42421, Saudi Arabia.
ORCID-Profile: Adil Abalkhail, Abdulaziz M Almuzaini, Mohammed Rawway, Abdelmaged Draz, Akram Abu-Okail
Förderung
- Deputyship for Research & Innovation, Ministry of Education, Saudi Arabia
Zitieren
APA
Elbehiry, A., Marzouk, E., Aldubaib, M., Abalkhail, A., Anagreyyah, S., Anajirih, N., Almuzaini, A. M., Rawway, M., Alfadhel, A., Draz, A., & Abu-Okail, A. (2023). Helicobacter pylori Infection: Current Status and Future Prospects on Diagnostic, Therapeutic and Control Challenges. Antibiotics, 12(2), 191. https://doi.org/10.3390/antibiotics12020191
Vancouver
Elbehiry A, Marzouk E, Aldubaib M, Abalkhail A, Anagreyyah S, Anajirih N, et al. Helicobacter pylori Infection: Current Status and Future Prospects on Diagnostic, Therapeutic and Control Challenges. Antibiotics. 2023;12(2):191. doi:10.3390/antibiotics12020191
BibTeX
@article{Elbehiry2023,
author = {Elbehiry, Ayman and Marzouk, Eman and Aldubaib, Musaad and Abalkhail, Adil and Anagreyyah, Sulaiman and Anajirih, Nuha and Almuzaini, Abdulaziz M and Rawway, Mohammed and Alfadhel, Abdulmajeed and Draz, Abdelmaged and Abu-Okail, Akram},
title = {Helicobacter pylori Infection: Current Status and Future Prospects on Diagnostic, Therapeutic and Control Challenges},
journal = {Antibiotics},
year = {2023},
volume = {12},
number = {2},
pages = {191},
doi = {10.3390/antibiotics12020191}
}
EUVIMED